Incidence  ||| S:0 E:10 ||| NN
of  ||| S:10 E:13 ||| IN
renal  ||| S:13 E:19 ||| JJ
replacement  ||| S:19 E:31 ||| NN
therapy  ||| S:31 E:39 ||| NN
in  ||| S:39 E:42 ||| IN
Veneto  ||| S:42 E:49 ||| NNP
for  ||| S:49 E:53 ||| IN
2008 ||| S:53 E:57 ||| CD
,  ||| S:57 E:59 ||| ,
2009  ||| S:59 E:64 ||| CD
and  ||| S:64 E:68 ||| CC
2010  ||| S:68 E:73 ||| CD
This  ||| S:73 E:78 ||| DT
section  ||| S:78 E:86 ||| NN
of  ||| S:86 E:89 ||| IN
the  ||| S:89 E:93 ||| DT
report  ||| S:93 E:100 ||| NN
of  ||| S:100 E:103 ||| IN
the  ||| S:103 E:107 ||| DT
Veneto  ||| S:107 E:114 ||| NNP
Dialysis  ||| S:114 E:123 ||| NNP
and  ||| S:123 E:127 ||| CC
Transplantation  ||| S:127 E:143 ||| NNP
Registry  ||| S:143 E:152 ||| NNP
( ||| S:152 E:153 ||| -LRB-
VDTR ||| S:153 E:157 ||| NNP
)  ||| S:157 E:159 ||| -RRB-
provides  ||| S:159 E:168 ||| VBZ
data  ||| S:168 E:173 ||| NNS
on  ||| S:173 E:176 ||| IN
the  ||| S:176 E:180 ||| DT
incidence  ||| S:180 E:190 ||| NN
of  ||| S:190 E:193 ||| IN
patients  ||| S:193 E:202 ||| NNS
receiving  ||| S:202 E:212 ||| VBG
renal  ||| S:212 E:218 ||| JJ
replacement  ||| S:218 E:230 ||| NN
therapy  ||| S:230 E:238 ||| NN
( ||| S:238 E:239 ||| -LRB-
RRT ||| S:239 E:242 ||| NNP
)  ||| S:242 E:244 ||| -RRB-
in  ||| S:244 E:247 ||| IN
the  ||| S:247 E:251 ||| DT
region  ||| S:251 E:258 ||| NN
from  ||| S:258 E:263 ||| IN
2008  ||| S:263 E:268 ||| CD
to  ||| S:268 E:271 ||| TO
2010 ||| S:271 E:275 ||| CD
.  ||| S:275 E:277 ||| .
Its  ||| S:277 E:281 ||| PRP$
purpose  ||| S:281 E:289 ||| NN
is  ||| S:289 E:292 ||| VBZ
to  ||| S:292 E:295 ||| TO
provide  ||| S:295 E:303 ||| VB
health  ||| S:303 E:310 ||| NN
authorities  ||| S:310 E:322 ||| NNS
with  ||| S:322 E:327 ||| IN
the  ||| S:327 E:331 ||| DT
information  ||| S:331 E:343 ||| NN
they  ||| S:343 E:348 ||| PRP
need  ||| S:348 E:353 ||| VBP
to  ||| S:353 E:356 ||| TO
plan  ||| S:356 E:361 ||| VB
the  ||| S:361 E:365 ||| DT
delivery  ||| S:365 E:374 ||| NN
of  ||| S:374 E:377 ||| IN
RRT  ||| S:377 E:381 ||| NNP
in  ||| S:381 E:384 ||| IN
Veneto ||| S:384 E:390 ||| NNP
.  ||| S:390 E:392 ||| .
Data  ||| S:392 E:397 ||| NNP
were  ||| S:397 E:402 ||| VBD
obtained  ||| S:402 E:411 ||| VBN
from  ||| S:411 E:416 ||| IN
the  ||| S:416 E:420 ||| DT
VDTR ||| S:420 E:424 ||| NNP
,  ||| S:424 E:426 ||| ,
defining  ||| S:426 E:435 ||| JJ
incident  ||| S:435 E:444 ||| NN
patients  ||| S:444 E:453 ||| NNS
according  ||| S:453 E:463 ||| VBG
to  ||| S:463 E:466 ||| TO
the  ||| S:466 E:470 ||| DT
recommendations  ||| S:470 E:486 ||| NNS
of  ||| S:486 E:489 ||| IN
the  ||| S:489 E:493 ||| DT
Italian  ||| S:493 E:501 ||| JJ
Dialysis  ||| S:501 E:510 ||| NNP
and  ||| S:510 E:514 ||| CC
Transplantation  ||| S:514 E:530 ||| NNP
Registry ||| S:530 E:538 ||| NNP
.  ||| S:538 E:540 ||| .
The  ||| S:540 E:544 ||| DT
incidence  ||| S:544 E:554 ||| JJ
rate  ||| S:554 E:559 ||| NN
was  ||| S:559 E:563 ||| VBD
calculated  ||| S:563 E:574 ||| VBN
per  ||| S:574 E:578 ||| IN
million  ||| S:578 E:586 ||| CD
population  ||| S:586 E:597 ||| NN
( ||| S:597 E:598 ||| -LRB-
pmp ||| S:598 E:601 ||| LS
) ||| S:601 E:602 ||| -RRB-
.  ||| S:602 E:604 ||| .
Variability  ||| S:604 E:616 ||| NNP
by  ||| S:616 E:619 ||| IN
province  ||| S:619 E:628 ||| NN
and  ||| S:628 E:632 ||| CC
treatment  ||| S:632 E:642 ||| NN
center  ||| S:642 E:649 ||| NN
was  ||| S:649 E:653 ||| VBD
studied  ||| S:653 E:661 ||| VBN
by  ||| S:661 E:664 ||| IN
applying  ||| S:664 E:673 ||| VBG
multilevel  ||| S:673 E:684 ||| JJ
modeling  ||| S:684 E:693 ||| NN
methods ||| S:693 E:700 ||| NNS
.  ||| S:700 E:702 ||| .
An  ||| S:702 E:705 ||| DT
age-period-cohort  ||| S:705 E:723 ||| JJ
model  ||| S:723 E:729 ||| NN
was  ||| S:729 E:733 ||| VBD
used  ||| S:733 E:738 ||| VBN
to  ||| S:738 E:741 ||| TO
forecast  ||| S:741 E:750 ||| VB
the  ||| S:750 E:754 ||| DT
incidence  ||| S:754 E:764 ||| JJ
rate  ||| S:764 E:769 ||| NN
of  ||| S:769 E:772 ||| IN
RRT  ||| S:772 E:776 ||| NNP
over  ||| S:776 E:781 ||| IN
the  ||| S:781 E:785 ||| DT
years  ||| S:785 E:791 ||| NNS
to  ||| S:791 E:794 ||| TO
come ||| S:794 E:798 ||| VB
.  ||| S:798 E:800 ||| .
The  ||| S:800 E:804 ||| DT
incidence  ||| S:804 E:814 ||| NN
of  ||| S:814 E:817 ||| IN
patients  ||| S:817 E:826 ||| NNS
on  ||| S:826 E:829 ||| IN
RRT  ||| S:829 E:833 ||| NNP
was  ||| S:833 E:837 ||| VBD
114.23  ||| S:837 E:844 ||| CD
pmp  ||| S:844 E:848 ||| NN
in  ||| S:848 E:851 ||| IN
2008 ||| S:851 E:855 ||| CD
,  ||| S:855 E:857 ||| ,
120.15  ||| S:857 E:864 ||| CD
pmp  ||| S:864 E:868 ||| NN
in  ||| S:868 E:871 ||| IN
2009  ||| S:871 E:876 ||| CD
and  ||| S:876 E:880 ||| CC
107.08  ||| S:880 E:887 ||| CD
pmp  ||| S:887 E:891 ||| NN
in  ||| S:891 E:894 ||| IN
2010 ||| S:894 E:898 ||| CD
.  ||| S:898 E:900 ||| .
The  ||| S:900 E:904 ||| DT
patients ||| S:904 E:912 ||| NNS
'  ||| S:912 E:914 ||| POS
median  ||| S:914 E:921 ||| JJ
age  ||| S:921 E:925 ||| NN
at  ||| S:925 E:928 ||| IN
the  ||| S:928 E:932 ||| DT
time  ||| S:932 E:937 ||| NN
of  ||| S:937 E:940 ||| IN
starting  ||| S:940 E:949 ||| VBG
RRT  ||| S:949 E:953 ||| NNP
was  ||| S:953 E:957 ||| VBD
70.5  ||| S:957 E:962 ||| CD
in  ||| S:962 E:965 ||| IN
2008 ||| S:965 E:969 ||| CD
,  ||| S:969 E:971 ||| ,
68.7  ||| S:971 E:976 ||| NNP
in  ||| S:976 E:979 ||| IN
2009  ||| S:979 E:984 ||| CD
and  ||| S:984 E:988 ||| CC
69.5  ||| S:988 E:993 ||| CD
in  ||| S:993 E:996 ||| IN
2010 ||| S:996 E:1000 ||| CD
.  ||| S:1000 E:1002 ||| .
During  ||| S:1002 E:1009 ||| IN
these  ||| S:1009 E:1015 ||| DT
3  ||| S:1015 E:1017 ||| CD
years ||| S:1017 E:1022 ||| NNS
,  ||| S:1022 E:1024 ||| ,
66.3 ||| S:1024 E:1028 ||| CD
%  ||| S:1028 E:1030 ||| NN
of  ||| S:1030 E:1033 ||| IN
patients  ||| S:1033 E:1042 ||| NNS
were  ||| S:1042 E:1047 ||| VBD
male ||| S:1047 E:1051 ||| JJ
,  ||| S:1051 E:1053 ||| ,
and  ||| S:1053 E:1057 ||| CC
33.7 ||| S:1057 E:1061 ||| CD
%  ||| S:1061 E:1063 ||| NN
were  ||| S:1063 E:1068 ||| VBD
female ||| S:1068 E:1074 ||| JJ
.  ||| S:1074 E:1076 ||| .
Incidence  ||| S:1076 E:1086 ||| JJ
rates  ||| S:1086 E:1092 ||| NNS
were  ||| S:1092 E:1097 ||| VBD
not  ||| S:1097 E:1101 ||| RB
uniformly  ||| S:1101 E:1111 ||| RB
distributed  ||| S:1111 E:1123 ||| VBN
between  ||| S:1123 E:1131 ||| IN
the  ||| S:1131 E:1135 ||| DT
provinces  ||| S:1135 E:1145 ||| NNS
in  ||| S:1145 E:1148 ||| IN
the  ||| S:1148 E:1152 ||| DT
region ||| S:1152 E:1158 ||| NN
,  ||| S:1158 E:1160 ||| ,
but  ||| S:1160 E:1164 ||| CC
were  ||| S:1164 E:1169 ||| VBD
significantly  ||| S:1169 E:1183 ||| RB
higher  ||| S:1183 E:1190 ||| JJR
in  ||| S:1190 E:1193 ||| IN
2 ||| S:1193 E:1194 ||| CD
.  ||| S:1194 E:1196 ||| .
The  ||| S:1196 E:1200 ||| DT
incidence  ||| S:1200 E:1210 ||| JJ
rate  ||| S:1210 E:1215 ||| NN
of  ||| S:1215 E:1218 ||| IN
patients  ||| S:1218 E:1227 ||| NNS
needing  ||| S:1227 E:1235 ||| VBG
RRT  ||| S:1235 E:1239 ||| NNP
seems  ||| S:1239 E:1245 ||| VBZ
likely  ||| S:1245 E:1252 ||| JJ
to  ||| S:1252 E:1255 ||| TO
remain  ||| S:1255 E:1262 ||| VB
stable  ||| S:1262 E:1269 ||| JJ
in  ||| S:1269 E:1272 ||| IN
the  ||| S:1272 E:1276 ||| DT
future ||| S:1276 E:1282 ||| NN
,  ||| S:1282 E:1284 ||| ,
until  ||| S:1284 E:1290 ||| IN
2015  ||| S:1290 E:1295 ||| CD
at  ||| S:1295 E:1298 ||| IN
least ||| S:1298 E:1303 ||| JJS
.  ||| S:1303 E:1305 ||| .
Renal  ||| S:1305 E:1311 ||| JJ
vascular  ||| S:1311 E:1320 ||| JJ
disease  ||| S:1320 E:1328 ||| NN
was  ||| S:1328 E:1332 ||| VBD
the  ||| S:1332 E:1336 ||| DT
primary  ||| S:1336 E:1344 ||| JJ
cause  ||| S:1344 E:1350 ||| NN
of  ||| S:1350 E:1353 ||| IN
end-stage  ||| S:1353 E:1363 ||| JJ
renal  ||| S:1363 E:1369 ||| JJ
disease  ||| S:1369 E:1377 ||| NN
( ||| S:1377 E:1378 ||| -LRB-
ESRD ||| S:1378 E:1382 ||| NNP
) ||| S:1382 E:1383 ||| -RRB-
,  ||| S:1383 E:1385 ||| ,
followed  ||| S:1385 E:1394 ||| VBD
closely  ||| S:1394 E:1402 ||| RB
by  ||| S:1402 E:1405 ||| IN
diabetes ||| S:1405 E:1413 ||| NN
,  ||| S:1413 E:1415 ||| ,
while  ||| S:1415 E:1421 ||| IN
the  ||| S:1421 E:1425 ||| DT
proportion  ||| S:1425 E:1436 ||| NN
due  ||| S:1436 E:1440 ||| JJ
to  ||| S:1440 E:1443 ||| TO
primary  ||| S:1443 E:1451 ||| JJ
glomerulonephritis  ||| S:1451 E:1470 ||| NN
has  ||| S:1470 E:1474 ||| VBZ
gradually  ||| S:1474 E:1484 ||| RB
decreased ||| S:1484 E:1493 ||| VBN
.  ||| S:1493 E:1495 ||| .
Initial  ||| S:1495 E:1503 ||| JJ
dialysis  ||| S:1503 E:1512 ||| NN
modality  ||| S:1512 E:1521 ||| NNS
was  ||| S:1521 E:1525 ||| VBD
hemodialysis  ||| S:1525 E:1538 ||| NNS
( ||| S:1538 E:1539 ||| -LRB-
HD ||| S:1539 E:1541 ||| NNP
)  ||| S:1541 E:1543 ||| -RRB-
for  ||| S:1543 E:1547 ||| IN
78 ||| S:1547 E:1549 ||| CD
%  ||| S:1549 E:1551 ||| NN
of  ||| S:1551 E:1554 ||| IN
patients ||| S:1554 E:1562 ||| NNS
,  ||| S:1562 E:1564 ||| ,
while  ||| S:1564 E:1570 ||| IN
about  ||| S:1570 E:1576 ||| IN
20 ||| S:1576 E:1578 ||| CD
%  ||| S:1578 E:1580 ||| NN
started  ||| S:1580 E:1588 ||| VBD
RRT  ||| S:1588 E:1592 ||| NNP
on  ||| S:1592 E:1595 ||| IN
peritoneal  ||| S:1595 E:1606 ||| JJ
dialysis  ||| S:1606 E:1615 ||| NN
( ||| S:1615 E:1616 ||| -LRB-
PD ||| S:1616 E:1618 ||| NNP
) ||| S:1618 E:1619 ||| -RRB-
,  ||| S:1619 E:1621 ||| ,
and  ||| S:1621 E:1625 ||| CC
a  ||| S:1625 E:1627 ||| DT
negligible  ||| S:1627 E:1638 ||| JJ
proportion  ||| S:1638 E:1649 ||| NN
had  ||| S:1649 E:1653 ||| VBD
a  ||| S:1653 E:1655 ||| DT
preemptive  ||| S:1655 E:1666 ||| JJ
kidney  ||| S:1666 E:1673 ||| NN
transplantation ||| S:1673 E:1688 ||| NN
.  ||| S:1688 E:1690 ||| .
About  ||| S:1690 E:1696 ||| IN
35 ||| S:1696 E:1698 ||| CD
%  ||| S:1698 E:1700 ||| NN
patients  ||| S:1700 E:1709 ||| NNS
began  ||| S:1709 E:1715 ||| VBD
dialysis  ||| S:1715 E:1724 ||| NN
with  ||| S:1724 E:1729 ||| IN
a  ||| S:1729 E:1731 ||| DT
temporary  ||| S:1731 E:1741 ||| JJ
vascular  ||| S:1741 E:1750 ||| JJ
catheter ||| S:1750 E:1758 ||| NN
;  ||| S:1758 E:1760 ||| :
this  ||| S:1760 E:1765 ||| DT
percentage  ||| S:1765 E:1776 ||| NN
remained  ||| S:1776 E:1785 ||| VBD
fairly  ||| S:1785 E:1792 ||| RB
constant  ||| S:1792 E:1801 ||| JJ
until  ||| S:1801 E:1807 ||| IN
2010 ||| S:1807 E:1811 ||| CD
.  ||| S:1811 E:1813 ||| .
The  ||| S:1813 E:1817 ||| DT
incidence  ||| S:1817 E:1827 ||| NN
of  ||| S:1827 E:1830 ||| IN
RRT  ||| S:1830 E:1834 ||| NNP
in  ||| S:1834 E:1837 ||| IN
Veneto  ||| S:1837 E:1844 ||| NNP
is  ||| S:1844 E:1847 ||| VBZ
one  ||| S:1847 E:1851 ||| CD
of  ||| S:1851 E:1854 ||| IN
the  ||| S:1854 E:1858 ||| DT
lowest  ||| S:1858 E:1865 ||| JJS
in  ||| S:1865 E:1868 ||| IN
Italy  ||| S:1868 E:1874 ||| NNP
and  ||| S:1874 E:1878 ||| CC
remained  ||| S:1878 E:1887 ||| VBD
substantially  ||| S:1887 E:1901 ||| RB
stable  ||| S:1901 E:1908 ||| JJ
over  ||| S:1908 E:1913 ||| IN
the  ||| S:1913 E:1917 ||| DT
period  ||| S:1917 E:1924 ||| NN
1998-2010 ||| S:1924 E:1933 ||| NN
,  ||| S:1933 E:1935 ||| ,
despite  ||| S:1935 E:1943 ||| IN
the  ||| S:1943 E:1947 ||| DT
population  ||| S:1947 E:1958 ||| NN
of  ||| S:1958 E:1961 ||| IN
patients  ||| S:1961 E:1970 ||| NNS
with  ||| S:1970 E:1975 ||| IN
ESRD  ||| S:1975 E:1980 ||| NNP
becoming  ||| S:1980 E:1989 ||| VBG
older  ||| S:1989 E:1995 ||| JJR
and  ||| S:1995 E:1999 ||| CC
more  ||| S:1999 E:2004 ||| RBR
severely  ||| S:2004 E:2013 ||| RB
ill ||| S:2013 E:2016 ||| JJ
.  ||| S:2016 E:2018 ||| .
This  ||| S:2018 E:2023 ||| DT
finding  ||| S:2023 E:2031 ||| NN
could  ||| S:2031 E:2037 ||| MD
mean  ||| S:2037 E:2042 ||| VB
a  ||| S:2042 E:2044 ||| DT
heavier  ||| S:2044 E:2052 ||| JJR
burden  ||| S:2052 E:2059 ||| NN
on  ||| S:2059 E:2062 ||| IN
the  ||| S:2062 E:2066 ||| DT
welfare  ||| S:2066 E:2074 ||| NN
system  ||| S:2074 E:2081 ||| NN
in  ||| S:2081 E:2084 ||| IN
the  ||| S:2084 E:2088 ||| DT
future ||| S:2088 E:2094 ||| NN
.  ||| S:2094 E:2096 ||| .
